Clovis Oncology, Inc. (CLVS) During the most recent session, the shares traded at 2.3 points or 3.2% higher at $74.23. The money flow data is unimpressive with the net money flow value of $(-1.16) million. As per the intraday data, the upticks measured $17.32 million and the downticks measured $18.48 million. As a result, the up/down ratio registered a value of 0.94. The shares have seen 18.96% price change for the week.A block trade also made an entry with $0 million flowing in through upticks while $1.43 million flew out through downticks. The block tradeoff had the up/down ratio of 0. The net money flow for this big transaction was $(-1.43) million.
Based on the Stock Research reports from financial advisors, there are 4 Analysts recommending as a Strong Buy, Investors should also note that 2 Stock brokerage firms are recommending to Hold the stock for short term. There are 1 Analysts recommending as a Strong Sell. Clovis Oncology, Inc. (NASDAQ:CLVS) witnessed a decline in the market cap on Thursday as its shares dropped 0.92% or 0.66 points. After the session commenced at $71.5, the stock reached the higher end at $74.94 while it hit a low of $70.39. With the volume soaring to 2,455,723 shares, the last trade was called at $71.27. The company has a 52-week high of $74.94. The company has a market cap of $3,181 million and there are 44,626,493 shares in outstanding. The 52-week low of the share price is $11.57.
Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations. Clovis Oncology Inc. is headquartered in Colorado, USA.